Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic

Hospital Pompeia

Status and phase

Completed

Phase 4

Conditions

Lung Cancer

Treatments

Drug: lidocaine

Drug: alfentanil

Drug: midazolam

Drug: propofol

Study type

Interventional

Funder types

Other

Identifiers

NCT00440960

0002.0.297.000-06

Details and patient eligibility

About

The objective of the study was to establish which anesthetic procedure used during flexible bronchoscopy has the lowest index of complications.

Full description

This prospective randomized study analyzed 80 patients that underwent flexible bronchoscopy. Patients were randomly assigned to four groups of 20 patients each according to the anesthetic combination used: 200 mg topical lidocaine (LID group); 200 mg topical lidocaine and 2 mg/kg propofol (PPF group); 200 mg topical lidocaine and 20 mcg/kg alfentanil (ALF group); or 200 mg topical lidocaine and 0.05 mg/kg midazolam (MID group). Scores were assigned to patients according to the different variables observed during the endoscopic procedure; the lower the score, the lower the complication index.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The patients included in this study were referred to FBC for the investigation of bronchial carcinoma (diagnostic procedure).
Patients included in the study were classified as ASA I, II and II according to the anesthetic risk classification of the American Society of Anesthesiologists (ASA).

Exclusion criteria